Prot # AI443131: Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects infected with Chronic Hepatitis C (FOURward Study)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/30/147/30/17

Funding

  • Bristol-Myers Squibb Company (AI443131)